Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma

Sao Paulo Medical Journal

Volumn 124, Issue 2, 2006, Pages 61-65

  Luisi, Flavio Augusto Vercillo ^a,b   Petrilli, Antônio Sérgio ^a   Tanaka, Cristiana ^a   Caran, Eliana Maria Monteiro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Adolescent; Child; Drug therapy; Nausea; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; DIMENHYDRINATE; EPIRUBICIN; GRANISETRON; IFOSFAMIDE; METOCLOPRAMIDE;

ADOLESCENT; ADULT; ANTICIPATORY NAUSEA AND VOMITING; ARTICLE; BRAZIL; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; NAUSEA; NAUSEA AND VOMITING; OPEN STUDY; OSTEOSARCOMA; PATIENT MONITORING; PEDIATRIC HOSPITAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SCHOOL CHILD; SINGLE DRUG DOSE; SOMNOLENCE; STATISTICAL ANALYSIS; STUDENT T TEST;

EID: 33746879962     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802006000200003     Document Type: Article

References (18)

1. Penta JS, Poster DS, Bruno S, Macdonald JS. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy. J Clin Pharmacol. 1981;21(8-9 Suppl):11S-22S.
2. Miller M, Kearney N. Chemotherapy-related nausea and vomitting - past reflections, present practice and future management. Eur J Cancer Care (Engl). 2004; 13(1):71-81.
3. Gralla RJ, Itri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Eng J Med. 1981:3050(16):905-9.
4. Kris MG, Gralla RJ, Tyson LB, et al. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 1985;55(3):527-34.
5. Terrin BN, McWilliams NB, Maurer HM, Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatt. 1984;104(1):138-40.
6. Allen JC, Gralla R, Reilly L, Kellick M, Young C. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol. 1985;3(8):1136-41.
7. Walton SM. Advances in use of the 5-HT3 receptor antagonists. Expert Opin Pharmacother. 2000; 1(2):207-23.
8. Miyajima Y, Numata S, Katayama I, Horibe K. Prevention of chemotheraphy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol 1994;16(3):236-41.
9. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer. 1995;76(3):343-57.
10. Carmichael J, Keizer HJ, Cupissol D, Milliez J, Scheidel P, Schindler AE. Use of granisetron in patients refractory to previous treatment with antiemetics. Anticancer Drugs. 1998;9(5):381-5.
11. Tan M. Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting. Expect Opin Pharmacother. 2003;4(9):1563-71.
12. Morrow GR. Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer. 1984;53(10 Suppl):2267-80.
13. Tsuchida Y, Hayashi Y, Asami K, et al. Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, cross-over study. Int J Oncol. 1999;14(4):673-9.
14. Lemerle J, Amaral D, Southall DP, Upward J, Murdoch RD. Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients. Eur J Cancer. 1991;27(9):1081-3.
15. Zucker JM, Quintana E, Hahlen K, Pinkerton CR, Baton F, Cedar E. IV granisetron in children: a randomized comparative study. Proceedings of the 29th Annual Meeting american Society of Clinical; 1993 May 16-18, Orlando, FL (abstract AI619).
16. Hirota T, Shimizu H, Fujimoto T, et al. [Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotheraphy]. Gan To Kagaku Ryoho. 1994;21(1):91-6.
17. Jacobson SJ, Shore RW, Greenberg M, Spielberg SP. The efficacy and safety of granisetron in pediatric cancer patients who had failed standard antiemetic therapy during anticancer chemotherapy. Am J Pediatr Hematol Oncol. 1994;16(3):231-5.
18. Morrow GR. Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer. 1984;53(10 Suppl):2267-80.